Literature DB >> 10791864

Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.

N Fournet1, O Moreaud, J L Roulin, B Naegele, J Pellat.   

Abstract

Cognitive impairments in Parkinson's disease (PD) could be explained by a central executive (CE) deficit in A. D. Baddeley's (1986) working memory model. To test this hypothesis, verbal, spatial, and double span tasks were given to 12 medicated PD patients and control participants, with varying recall delays. The double span task was assigned to explore the coordinating and integrating function of the CE, and lengthening the recall delay was expected to implicate more attentional resources. PD patients had lower spans relative to controls in all tasks. However, the more specific implication of the CE was difficult to prove. One reason could be that PD patients were on dopaminergic treatment when tested. To control this effect, 12 PD patients on and off medication were studied in a second experiment using the same tasks. PD patients off medication had lower spans only in the double task; this result underlines the role of dopamine on working memory processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791864     DOI: 10.1037//0894-4105.14.2.247

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  20 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Attention and reach-to-grasp movements in Parkinson's disease.

Authors:  Cathy Lu; Aamir Bharmal; Zelma H Kiss; Oksana Suchowersky; Angela M Haffenden
Journal:  Exp Brain Res       Date:  2010-06-29       Impact factor: 1.972

Review 3.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

4.  L-dopa impairs learning, but spares generalization, in Parkinson's disease.

Authors:  Daphna Shohamy; Catherine E Myers; Kindiya D Geghman; Jacob Sage; Mark A Gluck
Journal:  Neuropsychologia       Date:  2005-09-16       Impact factor: 3.139

5.  Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.

Authors:  R Ceravolo; D Volterrani; D Frosini; S Bernardini; C Rossi; C Logi; G Manca; L Kiferle; G Mariani; L Murri; U Bonuccelli
Journal:  J Neural Transm (Vienna)       Date:  2006-06-14       Impact factor: 3.575

6.  Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study.

Authors:  Ji Hyun Ko; Alain Ptito; Oury Monchi; Sang Soo Cho; Thilo Van Eimeren; Giovanna Pellecchia; Benedicte Ballanger; Pablo Rusjan; Sylvain Houle; Antonio P Strafella
Journal:  Neuroimage       Date:  2009-03-03       Impact factor: 6.556

7.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

8.  Enhanced frontal function in Parkinson's disease.

Authors:  R Cools; A Miyakawa; M Sheridan; M D'Esposito
Journal:  Brain       Date:  2009-12-07       Impact factor: 13.501

9.  The nature of working memory gating in Parkinson's disease: A multi-domain signal detection examination.

Authors:  Mitchell G Uitvlugt; Timothy J Pleskac; Susan M Ravizza
Journal:  Cogn Affect Behav Neurosci       Date:  2016-04       Impact factor: 3.282

10.  Spatial and object working memory deficits in Parkinson's disease are due to impairment in different underlying processes.

Authors:  Katherine L Possin; J Vincent Filoteo; David D Song; David P Salmon
Journal:  Neuropsychology       Date:  2008-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.